ClinicalTrials.Veeva

Menu

Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy

E

Egyptian Biomedical Research Network

Status

Completed

Conditions

Diabetic Peripheral Neuropathy

Treatments

Other: Placebo
Dietary Supplement: Green tea

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT04543422
EBRN298

Details and patient eligibility

About

the present randomized placebo-controlled study aimed to evaluate the effect of green tea extract administration on the clinical and neurophysiological parameters in patients with mild-to-moderate diabetic peripheral neuropathy.

Enrollment

200 patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetic patients with peripheral neuropathy

Exclusion criteria

  • Patients under treatment of diabetic peripheral neuropathy.
  • Patients with other causes of peripheral neuropathy.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups, including a placebo group

Green tea extracts
Experimental group
Description:
Patients in this arm received green tea extract capsules
Treatment:
Dietary Supplement: Green tea
Placebo
Placebo Comparator group
Description:
Patients in this arm received placebo treatment
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems